Top Markets
Coin of the day
Jeisys Medical Inc. Jeisys Medical Inc.

Jeisys Medical Inc.

287410
Pozycja w akcjach #11661
Jeisys Medical Inc. is a company dedicated to the innovation and production of... Jeisys Medical Inc. is a company dedicated to the innovation and production of medical equipment, catering to a range of healthcare professionals including plastic surgeons, dermatologists, and other clinicians. Operating from its headquarters in Seoul, South Korea, the firm serves both its domestic market and international clients. Its comprehensive product line addresses various aesthetic and dermatological concerns, offering solutions for skin revitalization, firming, pigment correction, fat reduction, acne treatment, tattoo removal, and the management of scars and stretch marks. These advanced systems are branded under names such as ULTRAcel Q+, Cellec V, LIPOcel, AcGen, TRI-BEAM Premium, Edge ONE, SmoothCool, and ULTRAcel. The company distributes its offerings through an extensive network of partners. Jeisys Medical Inc. was established in 2001.
Cena akcji
$8.92
Ostatnia synchronizacja: 2024-10-18
Kapitalizacja rynkowa
$674.03M
Zmiana (1 dzień)
-5.14%
Zmiana (1 rok)
0.00%
Kraj
KR
Handel Jeisys Medical Inc. (287410)

Kategoria

Zyski dla Jeisys Medical Inc. (287410)
Zyski w Jun 2024 TTM: $27.72M
Według najnowszych raportów finansowych Jeisys Medical Inc., obecny zysk firmy wynosi $27.72M. W roku 2022 firma osiągnęła zysk w wysokości $26.85M, wzrost w porównaniu do zysku z roku 2021, który wynosił $11.01M. Wyświetlany zysk to zysk przed odsetkami i podatkami, czyli EBIT.
Historia zysków firmy Jeisys Medical Inc. od 2020 do 2026
Zyski na koniec każdego roku
Rok Zyski Zmień
2026 (TTM) $27.72M 1.10%
2023 $27.42M 2.12%
2022 $26.85M 143.83%
2021 $11.01M 45.55%
2020 $7.57M 0.00%
Zyski podobnych firm lub konkurentów
Firma Zyski Różnica w zyskach Kraj
$7.51B 26,993.21%
US
$5.15B 18,469.54%
US
$5.56B 19,966.50%
IE
$3.86B 13,827.16%
US
- -
DE